$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
Unlocking Qiagen (QGEN) International Revenues: Trends, Surprises, and Prospects
10:22am, Monday, 05'th Aug 2024
Evaluate Qiagen's (QGEN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Qiagen N.V. (QGEN) Q2 2024 Earnings Call Transcript
03:04pm, Thursday, 01'st Aug 2024
Qiagen N.V. (NYSE:QGEN ) Q2 2024 Earnings Call Transcript Q2 2024 Earnings Conference Call August 1, 2024 9:00 AM ET Company Participants John Gilardi - Investor Relations Thierry Bernard - Chief Exec
QIAGEN (QGEN) Q2 Earnings Surpass Estimates, Margins Crash
09:40am, Thursday, 01'st Aug 2024
QIAGEN's (QGEN) earnings and revenues beat estimates in the second quarter. The company remains bullish on solid growth trends in the core business.
Compared to Estimates, Qiagen (QGEN) Q2 Earnings: A Look at Key Metrics
09:05pm, Wednesday, 31'st Jul 2024
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street es
Qiagen (QGEN) Tops Q2 Earnings and Revenue Estimates
08:40pm, Wednesday, 31'st Jul 2024
Qiagen (QGEN) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.53 per share a year ago.
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
04:06pm, Wednesday, 31'st Jul 2024
Q2 2024: Net sales of $496 million (+0% actual rates, +1% constant exchange rates, CER); net loss per share of $0.83 but adjusted diluted EPS of $0.55 // Net sales at CER of $502 million ahead of outl
Qiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?
11:07am, Wednesday, 24'th Jul 2024
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is QIAGEN (QGEN) a Good Investment Now? Key Factors to Note
09:55am, Thursday, 18'th Jul 2024
QIAGEN's (QGEN) progress in test menu expansion, prospects in molecular diagnostics and strong solvency bode well.
Qiagen (QGEN) Upgraded to Buy: What Does It Mean for the Stock?
01:05pm, Tuesday, 16'th Jul 2024
Qiagen (QGEN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
QIAGEN (QGEN) Expands in NGS and FIGG With New Partnership
11:01am, Tuesday, 09'th Jul 2024
QIAGEN (QGEN) announces a collaboration with the Snow Molecular Anthropology Lab at the University of Montana to enhance the identification of human remains of Indigenous people and African Americans.
QIAGEN N.V. to release results for Q2 2024 and hold webcast
09:29am, Tuesday, 02'nd Jul 2024
Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024.
QIAGEN (QGEN) Backs New AAP Guidelines Supporting QFT-Plus Test
09:25am, Friday, 28'th Jun 2024
QIAGEN (QGEN) supports the new TB screening guidelines from AAP, recommending IGRA tests like QFT-Plus to screen at-risk children of all ages.
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
04:05pm, Thursday, 27'th Jun 2024
American Academy of Pediatrics in the United States now recommends IGRA tests like QuantiFERON-TB Gold Plus to screen at-risk children of all ages // New recommendation joins trend of U.S. tuberculosi
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
09:10am, Wednesday, 19'th Jun 2024
QIAGEN's (QGEN) latest QCI Interpret release improves the performance of high-throughput NGS labs.
QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays
08:36am, Monday, 17'th Jun 2024
QIAGEN (QGEN) launches new QIAcuity dPCR assays for microbial applications, enhancing infectious disease research and surveillance.
Sign In
Buy QGEN